Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BICO Group AB Class B ( (SE:BICO) ) has shared an update.
BICO Group AB has appointed Fraser McLeod as the new Managing Director of its subsidiary, Biosero, effective September 22, 2025. With extensive experience in the life sciences industry, McLeod is expected to drive sustainable growth and strengthen Biosero’s position in providing automated and data-driven lab solutions. This strategic move aligns with BICO’s 2.0 strategy, aiming to enhance the company’s market positioning and create long-term value for customers and stakeholders.
The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK36.00 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.
More about BICO Group AB Class B
BICO Group AB is a prominent player in the lab automation industry, providing innovative solutions and workflows to the pharmaceutical and biotech sectors. With over 48,000 instruments installed globally, BICO’s products and software are integral to more than 3,500 laboratories, including the top 20 pharmaceutical companies worldwide. The company operates through two main business areas: Lab Automation and Life Science Solutions, striving to automate future life science labs.
YTD Price Performance: -28.67%
Average Trading Volume: 283,769
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.61B
For detailed information about BICO stock, go to TipRanks’ Stock Analysis page.